The groundbreaking success of the copyright undeniably reshaped the pharmaceutical landscape, but placing funds in companies strongly reliant on generic versions presents a complex picture. Although click here early profits were substantial, the expiration of patents and the rise of less expensive alternatives have weakened sales. Consequently, a t